Systemic corticosteroids in the phenytoin hypersensitivity syndrome

British Journal of Dermatology

Volumn 134, Issue 6, 1996, Pages 1109-1112

  Chopra, S ^a,b   Levell, N J ^a   Cowley, G ^a   Gilkes, J J H ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CORTICOSTEROID; ERYTHROMYCIN; PHENYTOIN; PREDNISOLONE; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG HYPERSENSITIVITY; EPILEPSY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029899864     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb07953.x     Document Type: Article

References (19)

1. Silverman AK, Fairley J, Wong RC. Cutaneous and immunologic reaction to phenytoin. J Am Acad Dermatol 1988; 18: 721-41.
2. Swart E, Lochner JD. Skin conditions in epileptics. Clin Exp Dermatol 1992; 17: 169-72.
3. Klier RS, Brenan DL, Boiko S. Generalised pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol 1991l 127: 1361-4.
4. Harris DW, Ostlere L, Buckley C et al. Phenytoin induced pseudolymphoma. A report of a case and review of the literature. Br J Dermatol 1992; 127: 403-6.
5. Stanley J. Fallon-Pellici. Phenytoin hypersensitivity reaction. Arch Dermatol 1978; 14: 1350-3.
6. Robinson HM, Stone JH. Exanthem due to diphenylhydantoin therapy. Arch Dermatol 1970; 101: 462-5.
7. Pezzimenti JF, Hahn AL. Anicteric hepatitis induced by diphenylhydantoin. Arch Intern Med 1970: 125: 118-20.
8. Anderson VM, Bauer HM, Kelly AP. Mucocutaneous lymph node syndrome in an adult receiving diphenylhydantoin. Cutis 1979; 23: 493-8.
9. Huijgens PC, Thijs LG, den Ottolander GJ. Pure red cell aplasia. toxic dermatitis and lymphadenopathy in a patient taking diphenylhydantoin. Acta Haematol 1978; 9: 31-6.
10. Fruchter L, Laptook A. Diphenylhydantoin hypersensitivity reaction associated with interstitial pulmonary infiltrates and hypereosinophilia. Ann Allergy 1981; 47: 453-4.
11. Mahaley MS, Dudka L. The role of anticonvulsant medications in the management of patients with anaplastic gliomas. Surg Neurol 1981; 16: 399-401.
12. Gaffey CM, Chun B, Harvey JC et al. Phenytoin induced systemic granulomatous vasculitis. Arch Pathol Lab Med 1986; 110: 131-5.
13. Targan SR, Chassin MRG, Guze LB. Dilantin-induced disseminated intravascular coagulation with purpura fulminans. A case report. Ann Intern Med 1975; 83: 227-30.
14. Dhar GJ, Ahamed PN, Pierach CA. Diphenylhydantoin-induced hepatic necrosis. Postgrad Med 1974; 56: 128-34.
15. Weedon AP. Diphenylhydantoin sensitivity. A syndrome resembling infectious mononucleosis with a morbilliform rash and cholestatic hepatitis. Aust NZ J Med 1975; 5: 561-3.
16. Aviakian R, Flowers FP, Araujo OE et al. Toxic epidermal necrolysis: a review. J Am Acad Dermatol 1991; 25: 69-79.
17. Gropper AL. Diphenylhydantoin sensitivity. Report of fatal case with hepatitis and exfoliative dermatitis. N Engl J Med 1956; 254: 522-3.
18. Michael JR, Mitch WE. Reversible renal failure and myositis caused by phenytoin hypersensitivity. JAMA 1976; 236: 2773-4.
19. Lee TJ, Charles N, Carney MD et al. Diphenylhydantoin-induced hepatic necrosis. Gastroenterology 1976; 70: 422-4.